These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 16888780)

  • 1. FAP-1-mediated activation of NF-kappaB induces resistance of head and neck cancer to Fas-induced apoptosis.
    Wieckowski E; Atarashi Y; Stanson J; Sato TA; Whiteside TL
    J Cell Biochem; 2007 Jan; 100(1):16-28. PubMed ID: 16888780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid up-regulation of c-FLIP expression by BCR signaling through the PI3K/Akt pathway inhibits simultaneously induced Fas-mediated apoptosis in murine B lymphocytes.
    Moriyama H; Yonehara S
    Immunol Lett; 2007 Mar; 109(1):36-46. PubMed ID: 17275920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.
    Huerta-Yepez S; Vega M; Garban H; Bonavida B
    Clin Immunol; 2006 Sep; 120(3):297-309. PubMed ID: 16784892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human T-cell leukemia virus type-I oncoprotein Tax inhibits Fas-mediated apoptosis by inducing cellular FLIP through activation of NF-kappaB.
    Okamoto K; Fujisawa J; Reth M; Yonehara S
    Genes Cells; 2006 Feb; 11(2):177-91. PubMed ID: 16436054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NF-kappaB protects Behçet's disease T cells against CD95-induced apoptosis up-regulating antiapoptotic proteins.
    Todaro M; Zerilli M; Triolo G; Iovino F; Patti M; Accardo-Palumbo A; di Gaudio F; Turco MC; Petrella A; de Maria R; Stassi G
    Arthritis Rheum; 2005 Jul; 52(7):2179-91. PubMed ID: 15986355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of FLIP in cisplatin-selected HeLa cells causes cross-resistance to CD95/Fas death signalling.
    Kamarajan P; Sun NK; Chao CC
    Biochem J; 2003 Nov; 376(Pt 1):253-60. PubMed ID: 12911332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FAS death domain deletions and cellular FADD-like interleukin 1beta converting enzyme inhibitory protein (long) overexpression: alternative mechanisms for deregulating the extrinsic apoptotic pathway in diffuse large B-cell lymphoma subtypes.
    Takahashi H; Feuerhake F; Kutok JL; Monti S; Dal Cin P; Neuberg D; Aster JC; Shipp MA
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3265-71. PubMed ID: 16740746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to Fas-mediated apoptosis in malignant tumours is rescued by KN-93 and cisplatin via downregulation of c-FLIP expression and phosphorylation.
    Yang BF; Xiao C; Li H; Yang SJ
    Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1245-51. PubMed ID: 17973862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of genes that regulate Fas signalling and Fas-mediated apoptosis in colon carcinoma cells.
    Tillman DM; Harwood FG; Gibson AA; Houghton JA
    Cell Death Differ; 1998 May; 5(5):450-7. PubMed ID: 10200495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of mcl-1 by small interfering RNA sensitizes resistant melanoma cells to fas-mediated apoptosis.
    Chetoui N; Sylla K; Gagnon-Houde JV; Alcaide-Loridan C; Charron D; Al-Daccak R; Aoudjit F
    Mol Cancer Res; 2008 Jan; 6(1):42-52. PubMed ID: 18234961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The fas signaling pathway is functional in colon carcinoma cells and induces apoptosis.
    Houghton JA; Harwood FG; Gibson AA; Tillman DM
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2205-9. PubMed ID: 9815616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis.
    Ungefroren H; Voss M; Jansen M; Roeder C; Henne-Bruns D; Kremer B; Kalthoff H
    Cancer Res; 1998 Apr; 58(8):1741-9. PubMed ID: 9563493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of FAP-1 by human colon adenocarcinoma: implication for resistance against Fas-mediated apoptosis in cancer.
    Yao H; Song E; Chen J; Hamar P
    Br J Cancer; 2004 Nov; 91(9):1718-25. PubMed ID: 15494722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas-mediated apoptosis and expression of related genes in human malignant hematopoietic cells.
    Kim KM; Lee K; Hong YS; Park HY
    Exp Mol Med; 2000 Dec; 32(4):246-54. PubMed ID: 11190279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inducible resistance to Fas-mediated apoptosis in B cells.
    Rothstein TL
    Cell Res; 2000 Dec; 10(4):245-66. PubMed ID: 11191348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo expression of soluble Fas and FAP-1: possible mechanisms of Fas resistance in human hepatoblastomas.
    Lee SH; Shin MS; Lee JY; Park WS; Kim SY; Jang JJ; Dong SM; Na EY; Kim CS; Kim SH; Yoo NJ
    J Pathol; 1999 Jun; 188(2):207-12. PubMed ID: 10398166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of death receptor-mediated apoptosis in differentiating human myeloid leukemia HL-60 cells.
    Vondrácek J; Sheard MA; Krejcí P; Minksová K; Hofmanová J; Kozubík A
    J Leukoc Biol; 2001 May; 69(5):794-802. PubMed ID: 11358989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes.
    Gastman BR; Atarshi Y; Reichert TE; Saito T; Balkir L; Rabinowich H; Whiteside TL
    Cancer Res; 1999 Oct; 59(20):5356-64. PubMed ID: 10537320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fas signaling in thyroid carcinomas is diverted from apoptosis to proliferation.
    Mitsiades CS; Poulaki V; Fanourakis G; Sozopoulos E; McMillin D; Wen Z; Voutsinas G; Tseleni-Balafouta S; Mitsiades N
    Clin Cancer Res; 2006 Jun; 12(12):3705-12. PubMed ID: 16778096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
    Müllauer L; Mosberger I; Grusch M; Rudas M; Chott A
    J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.